Proton pump inhibitors and hypomagnesemia monitoring
Author:
Open Access
- 1 August 2013
- journal article
- Published by Taylor & Francis in International Journal of General Medicine
- Vol. 6, 675-676
Abstract
Proton pump inhibitors and hypomagnesemia monitoring Thomas I LemonInstitute of Medical Education, Cardiff University School of Medicine, Cardiff, UK I thank El-Charabaty et al1 for their interesting paper which concludes that patients in receipt of proton pump inhibitors (PPIs) need to be followed closely for magnesium deficiency, particularly in the face of acute cardiovascular events, as this may worsen arrhythmias and hence increase the likelihood of complications. I would of course reference Faulheber et al’s recent paper that highlights the fact that hypomagnesemia in PPI use is uncommon2 – but of course, uncommon does not mean never, and as such the former’s conclusion is sound advice to all juniors and seniors alike.View original paper by El-Charabaty and colleagues.Keywords
This publication has 2 references indexed in Scilit:
- Effects of proton pump inhibitors and electrolyte disturbances on arrhythmiasInternational Journal of General Medicine, 2013
- Serum magnesium and proton-pump inhibitors use: a cross-sectional studyRevista da Associação Médica Brasileira, 2013